Cancer Council have launched a new nationwide campaign to increase participation in the National Bowel Cancer Screening Program (NBCSP). This campaign is thanks to $10 million received from the Federal Government to encourage more Australians to screen.
The NBCSP is one of Australia’s most important public health programs. The program has the potential to prevent 83,800 bowel cancer deaths by 2040 if program participation increases to 60%. In 2016-2017, only 41.3% of eligible Australians participated in the NBCSP.
We will target Australians aged 50-74 through TV, radio, outdoor, and digital advertising and encourage them to do the at-home test when they receive it in the mail.
Health professionals are integral to the success of this campaign and the NBCSP. Evidence shows that a recommendation during consultation is a key motivator to screen. You can promote participation through:
- Endorsing the program by displaying brochures and posters,
- Encouraging patients aged 50-74 to do the test by:
- Undertaking an audit of practice records and sending a letter or SMS to under- screened patients aged 50-74 encouraging participation,
- Demonstrating how to use the NBCSP kit with eligible patients,
- Sending a letter or SMS to patients nearing their 50th birthday to encourage them to complete the test when they first receive it.
Resources to help health professionals support this campaign, including tips for encouraging participation, instructional videos, clinical guidelines and FAQs, are available at http://www.cancerscreening.gov.au/health-professionals.
People with cancer have higher rates of mental illness: that’s why Cancer Council Victoria made a submission to the Royal Commission into Mental Health
Cancer Council is working to reduce the cost of cancer for Victorians. If you know someone that has been adversely affected, please encourage them to join our advoacy work to help others.
A global clinical trial led in Europe and Australia by Colebatch Fellowship recipient, Prof Kelly-Anne Phillips, has identified a treatment that helps prevent early onset of menopause in young women treated with chemotherapy for breast cancer.
Research linking some breast implants to a rare cancer, and the subsequent world-wide recall, has caused confusion at an already difficult time for people with breast cancer.